Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ireland adds new vaccines to paediatric immunisation programme

This article was originally published in Scrip

Executive Summary

Ireland's Immunisation Guidelines 2008 has added two new vaccines to the primary childhood immunisation programme, and modified the timing of two other innoculations.Pneumococcal conjugate vaccine (PCV) will be added to the programme, along with the addition of a hepatitis B vaccine to the 5 in 1 vaccine, which currently protects against diphtheria, tetanus, whooping cough, Hib and polio. Changes in the timing of administration of the meningococcal C and Haemophilus (Hib) vaccines have also been made, reflecting recommendations for their inclusion in primary immunisation schedules at three to four months. The programme, produced by the National Immunisation Advisory Committee (NIAC) of the Royal College of Physicians of Ireland, serves to update the previous 2002 guidelines and help Ireland achieve its childhood immunisation goal of 95% uptake. Children are immunised free of charge under the programme.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC003230

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel